No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Wednesday, March 25, 2026
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

PhonePe gets Sebi nod for IPO; Microsoft, Walmart to pare stake in OFS

by TheAdviserMagazine
2 months ago
in Business
Reading Time: 2 mins read
A A
PhonePe gets Sebi nod for IPO; Microsoft, Walmart to pare stake in OFS
Share on FacebookShare on TwitterShare on LInkedIn


Walmart-backed digital payments major PhonePe has received approval from capital markets regulator Sebi to proceed with its IPO, according to sources. This clears a key regulatory hurdle for what is expected to be one of the largest fintech listings in the Indian market. The approval comes at a time when investor interest in large, consumer-facing technology platforms is relatively stable despite the talk around valuations.

Earlier reports indicate that PhonePe is targeting around $1.5 billion through the public issue, even though the quantum of the fundraise could change closer to the IPO. The public offer will be a complete offer for sale (OFS), where Tiger Global, Microsoft and Walmart will offer part of their shares, sources said.

PhonePe’s last reported valuation stood at $14.5 billion following a $600 million funding round led by General Atlantic in late 2025. This marked a sharp step-up from its $12.5 billion valuation in May 2023, underlining renewed investor confidence in the company’s scale, market leadership and path to profitability.

Founded in December 2015, PhonePe has emerged as India’s largest digital payments platform over the past decade. The company currently has more than 43.5 crore registered users, meaning roughly one in four Indians uses PhonePe in some form. On the merchant side, it has onboarded close to 3.5 crore offline merchants across Tier 2, Tier 3 and smaller towns, with coverage extending to 99% of India’s pin codes.

The platform has also built a dominant position in the Bharat Bill Payment System, where it processes over 45% of all transactions on the BBPS network. In December 2025 alone, PhonePe processed 9.8 billion transactions, according to data released by the National Payments Corporation of India.

Live Events

Beyond payments, PhonePe has steadily expanded into financial services since 2017. The company offers a range of mutual funds and insurance products, positioning itself as a broader financial services marketplace rather than just a payments app. This diversification has been central to its long-term strategy, especially as competition in core UPI payments intensifies.Financially, PhonePe has shown signs of operating leverage. The company narrowed its net loss by 13.4% in 2024-25 to Rs 1,727 crore, compared with a loss of Rs 1,996 crore in the previous year. Operating revenue during the year rose 40% to Rs 7,115 crore from Rs 5,064 crore.Also Read: Rs 9 lakh crore wipeout! Sensex crashes over 1,000 points, Nifty below 25,250. Here are 5 factors pulling the stock market lower

The IPO will be managed by a consortium of global and domestic investment banks, including Kotak Mahindra Capital, JPMorgan Chase, Citigroup and Morgan Stanley.

With Sebi approval now in hand, PhonePe is likely to move towards launching its issue, although the timing will depend on the sentiments in the secondary market, which are going through a volatile period currently.

(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)



Source link

Tags: IPOMicrosoftNodOFSparePhonePeSEBIstakeWalmart
ShareTweetShare
Previous Post

Chief Tax Officer and Lead Tax Attorney at Optima Tax Relief, Phil Hwang, Appointed National Chair of IRS Taxpayer Advocacy Panel

Next Post

8 Stocks That Could Stay Resilient as Trump’s Tariff Threats Rattle Markets

Related Posts

edit post
Iran claims U.S. is negotiating with itself; here’s what Tehran is demanding

Iran claims U.S. is negotiating with itself; here’s what Tehran is demanding

by TheAdviserMagazine
March 25, 2026
0

Mar 25, 2026, 4:40 AM ETProShares Ultra Bloomberg Crude Oil ETF (UCO), SCO, BNO, DBO, DBE, GUSH, OILK, MLPX, DRIP,...

edit post
China could be the ‘big winner’ in the AI race, thanks to abundant power, cheap manufacturing, and an open-source craze

China could be the ‘big winner’ in the AI race, thanks to abundant power, cheap manufacturing, and an open-source craze

by TheAdviserMagazine
March 25, 2026
0

When Jensen Huang praised OpenClaw last week, the ripples reached Hong Kong within hours. Shares in MiniMax and Zhipu AI...

edit post
D-Street rebounds as US halts Iran strikes; Nifty jumps nearly 2%

D-Street rebounds as US halts Iran strikes; Nifty jumps nearly 2%

by TheAdviserMagazine
March 24, 2026
0

Mumbai: Indian equities on Tuesday expectedly tracked a pan-Asian rebound in risk assets to climb nearly 2% while the rupee...

edit post
BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)

BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)

by TheAdviserMagazine
March 24, 2026
0

Earnings Call Insights: BioCardia (BCDA) Q4 2025 Management View Peter Altman, CEO, highlighted that BioCardia now has complete and final...

edit post
Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 (NASDAQ:GUTS)

Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 (NASDAQ:GUTS)

by TheAdviserMagazine
March 24, 2026
0

Follow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock newsEarnings Call Insights:...

edit post
Moldova imposes 60-day energy emergency after Russian strikes in Ukraine

Moldova imposes 60-day energy emergency after Russian strikes in Ukraine

by TheAdviserMagazine
March 24, 2026
0

Moldova’s Parliament voted on Tuesday to impose a state of emergency in the country’s energy sector after Russian strikes on neighboring...

Next Post
edit post
8 Stocks That Could Stay Resilient as Trump’s Tariff Threats Rattle Markets

8 Stocks That Could Stay Resilient as Trump’s Tariff Threats Rattle Markets

edit post
ITC Hotels Q3 Results: PAT jumps 77% YoY to Rs 235 crore, revenue rises 47%

ITC Hotels Q3 Results: PAT jumps 77% YoY to Rs 235 crore, revenue rises 47%

  • Trending
  • Comments
  • Latest
edit post
Foreclosure Starts are Up 19%—These Counties are Seeing the Highest Distress

Foreclosure Starts are Up 19%—These Counties are Seeing the Highest Distress

February 24, 2026
edit post
Publix to Open 5 New Stores by End of April. See Upcoming Locations.

Publix to Open 5 New Stores by End of April. See Upcoming Locations.

March 20, 2026
edit post
7 States Reporting a Surge in Norovirus Cases

7 States Reporting a Surge in Norovirus Cases

February 22, 2026
edit post
The Growing Movement to End Property Taxes Continues in Kentucky, And What It Means For Investors

The Growing Movement to End Property Taxes Continues in Kentucky, And What It Means For Investors

March 2, 2026
edit post
Who Is Legally Next of Kin in North Carolina?

Who Is Legally Next of Kin in North Carolina?

February 28, 2026
edit post
Georgia’s 0 Tax Rebate Is Moving Forward — Here’s When You Can Expect Your 2026 Check

Georgia’s $250 Tax Rebate Is Moving Forward — Here’s When You Can Expect Your 2026 Check

March 21, 2026
edit post
Bitcoin faces a new threat after US PMI reignites stagflation fears

Bitcoin faces a new threat after US PMI reignites stagflation fears

0
edit post
Rothbard on Interventionism: Writing the Last Chapter of Economic Theory

Rothbard on Interventionism: Writing the Last Chapter of Economic Theory

0
edit post
Iran claims U.S. is negotiating with itself; here’s what Tehran is demanding

Iran claims U.S. is negotiating with itself; here’s what Tehran is demanding

0
edit post
Quiz: What’s Your “Tax Vibe”?

Quiz: What’s Your “Tax Vibe”?

0
edit post
Iran war makes Middle East peace prospects better long-term

Iran war makes Middle East peace prospects better long-term

0
edit post
China could be the ‘big winner’ in the AI race, thanks to abundant power, cheap manufacturing, and an open-source craze

China could be the ‘big winner’ in the AI race, thanks to abundant power, cheap manufacturing, and an open-source craze

0
edit post
Iran claims U.S. is negotiating with itself; here’s what Tehran is demanding

Iran claims U.S. is negotiating with itself; here’s what Tehran is demanding

March 25, 2026
edit post
China could be the ‘big winner’ in the AI race, thanks to abundant power, cheap manufacturing, and an open-source craze

China could be the ‘big winner’ in the AI race, thanks to abundant power, cheap manufacturing, and an open-source craze

March 25, 2026
edit post
Mapping The Ocean Floor – The Next War Will Be Fought In Silence

Mapping The Ocean Floor – The Next War Will Be Fought In Silence

March 25, 2026
edit post
Bitcoin, XRP Rallies Won’t Hold Until Oil Falls Toward , Expert Warns

Bitcoin, XRP Rallies Won’t Hold Until Oil Falls Toward $80, Expert Warns

March 24, 2026
edit post
D-Street rebounds as US halts Iran strikes; Nifty jumps nearly 2%

D-Street rebounds as US halts Iran strikes; Nifty jumps nearly 2%

March 24, 2026
edit post
BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)

BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)

March 24, 2026
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Iran claims U.S. is negotiating with itself; here’s what Tehran is demanding
  • China could be the ‘big winner’ in the AI race, thanks to abundant power, cheap manufacturing, and an open-source craze
  • Mapping The Ocean Floor – The Next War Will Be Fought In Silence
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.